Clinical Trial Update: JC-Virus (JCV) Antibody Program

View source ↗

Summary

Biogen reports completion of its JC-Virus antibody program related to multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Biogen | Conditions: Multiple Sclerosis | Status: COMPLETED